Leeward Investments LLC MA decreased its position in shares of The AZEK Company Inc. (NYSE:AZEK - Free Report) by 17.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 149,018 shares of the company's stock after selling 30,798 shares during the period. Leeward Investments LLC MA owned about 0.10% of AZEK worth $7,074,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently modified their holdings of the company. Empowered Funds LLC acquired a new stake in shares of AZEK in the 4th quarter valued at $27,000. Farther Finance Advisors LLC boosted its holdings in AZEK by 183.1% in the third quarter. Farther Finance Advisors LLC now owns 753 shares of the company's stock valued at $35,000 after acquiring an additional 487 shares during the last quarter. GAMMA Investing LLC increased its position in AZEK by 39.1% in the fourth quarter. GAMMA Investing LLC now owns 851 shares of the company's stock worth $40,000 after purchasing an additional 239 shares during the period. Blue Trust Inc. raised its holdings in AZEK by 106.4% during the 3rd quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $44,000 after purchasing an additional 480 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in AZEK during the 3rd quarter valued at about $59,000. Institutional investors own 97.44% of the company's stock.
Insider Buying and Selling at AZEK
In other AZEK news, CEO Jesse G. Singh sold 19,613 shares of the business's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $44.98, for a total transaction of $882,192.74. Following the sale, the chief executive officer now directly owns 904,152 shares of the company's stock, valued at $40,668,756.96. The trade was a 2.12 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CMO Samara Toole sold 1,709 shares of the stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $53.00, for a total transaction of $90,577.00. Following the transaction, the chief marketing officer now owns 16,632 shares of the company's stock, valued at approximately $881,496. This represents a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 61,709 shares of company stock valued at $3,060,151 in the last 90 days. 3.20% of the stock is currently owned by company insiders.
AZEK Stock Down 1.6 %
Shares of AZEK traded down $0.75 on Thursday, hitting $45.86. The company's stock had a trading volume of 839,746 shares, compared to its average volume of 1,617,417. The firm's fifty day moving average price is $49.06 and its 200-day moving average price is $47.01. The AZEK Company Inc. has a fifty-two week low of $35.48 and a fifty-two week high of $54.91. The company has a quick ratio of 1.19, a current ratio of 2.56 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $6.59 billion, a price-to-earnings ratio of 46.32, a P/E/G ratio of 1.91 and a beta of 1.94.
AZEK (NYSE:AZEK - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.03. AZEK had a net margin of 9.85% and a return on equity of 13.47%. On average, equities research analysts expect that The AZEK Company Inc. will post 1.34 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Barclays boosted their price target on shares of AZEK from $58.00 to $64.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 11th. BMO Capital Markets upped their target price on shares of AZEK from $52.00 to $54.00 and gave the company a "market perform" rating in a research report on Thursday, February 6th. Robert W. Baird raised their price target on AZEK from $54.00 to $58.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 5th. Benchmark reiterated a "buy" rating and issued a $55.00 price objective on shares of AZEK in a report on Thursday, November 21st. Finally, Royal Bank of Canada increased their target price on AZEK from $50.00 to $58.00 and gave the company an "outperform" rating in a research note on Friday, December 13th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $54.85.
Check Out Our Latest Report on AZEK
About AZEK
(
Free Report)
The AZEK Company Inc engages in the design, manufacturing, and selling of building products for residential, commercial, and industrial markets in the United States and Canada. It operates through two segments: Residential and Commercial. The Residential segment designs and manufactures engineered outdoor living products, such as decking, railing, trim and molding, siding and cladding, pergolas and cabanas, and accessories under the TimberTech, AZEK Exteriors, VERSATEX, ULTRALOX, StruXure, and INTEX brands.
Featured Stories

Before you consider AZEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AZEK wasn't on the list.
While AZEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.